Evidence map›Paper›PMID 32398107›Full record

ArticleAIDS research and therapy2020

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.

Joseph Fokam, Armanda Nangmo, Carlson Wandum, Desire Takou, Maria Mercedes Santoro, Anne-Esther Njom Nlend, Francis Ndongo Ateba, Paul Koki Ndombo, Nelly Kamgaing, Cedric Kamta and 7 more

Open access · goldAbstract read
In one paragraph

Article in AIDS research and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Joseph FokamVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon. josephfokam@gmail.com.ORCID 0000-0002-1501-2763
Armanda NangmoVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon.
Carlson WandumVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon.
Desire TakouVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon.
Maria Mercedes SantoroUniversity of Rome Tor Vergata (UTV), Rome, Italy.
Anne-Esther Njom NlendNational Social Welfare Hospital (NSWFH), Yaoundé, Cameroon.
Francis Ndongo AtebaMother-Child Centre of the Chantal BIYA's Foundation (MCC-CBF), Yaoundé, Cameroon.
Paul Koki NdomboFaculty of Medicine and Biomedical Sciences (FMSB), University of Yaoundé I, Yaoundé, Cameroon.
Nelly KamgaingUniversity Teaching Hospital (UTH), Yaoundé, Cameroon.
Cedric KamtaMfou District Hospital (MDH), Mfou, Cameroon.
Andre EssianeMbalmayo District Hospital (MDH), Mbalmayo, Cameroon.
Virginie LamboNkomo Medical Center (NMC), Nkomo, Cameroon.
Charles FokunangFaculty of Medicine and Biomedical Sciences (FMSB), University of Yaoundé I, Yaoundé, Cameroon.
Dora MbanyaFaculty of Medicine and Biomedical Sciences (FMSB), University of Yaoundé I, Yaoundé, Cameroon.
Vittorio ColizziVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon.
Carlo-Federico PernoVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon.
Alexis NdjoloVirology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), P.O BOX: 3077, Messa, Yaoundé, Cameroon.
Université de Yaoundé I · CMUniversity of Bamenda · CMUniversity of Rome Tor Vergata · ITCentre International De Reference Chantal Biya · CMUniversity Teaching Hospital of Yaounde · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high rate of mortality among HIV-vertically infected adolescents might be favoured by HIV drug resistance (HIVDR) emergence, which calls for timeous actions in this underserved population. We thus sought to evaluate program quality indicators (PQIs) of HIVDR among HIV-vertically infected adolescents on antiretroviral therapy (ART).

methodsA study was conducted in the Centre region of Cameroon among adolescents (10-19 years) receiving ART in two urban (The Mother-Child Centre of the Chantal BIYA Foundation, the National Social Welfare Hospital) and three rural (Mfou District Hospital, Mbalmayo District Hospital and Nkomo Medical Center) health facilities. Following an exhaustive sampling from ART registers, patient medical files and pharmacy records, data was abstracted for seven PQIs: on-time drug pick-up; retention in care; pharmacy stock outs; dispensing practices; viral load coverage; viral suppression and adequate switch to second-line. Performance in PQIs was interpreted following the WHO-recommended thresholds (desirable, fair and/or poor); with p < 0.05 considered significant.

resultsAmong 967 adolescents (888 urban versus 79 rural) registered in the study sites, validated data was available for 633 (554 in urban and 79 in rural). Performance in the urban vs. rural settings was respectively: on-time drug pick-up was significantly poorer in rural (79% vs. 46%, p = 0.00000006); retention in care was fair in urban (80% vs. 72%, p = 0.17); pharmacy stock outs was significantly higher in urban settings (92% vs. 50%, p = 0.004); dispensing practices was desirable (100% vs. 100%, p = 1.000); viral load coverage was desirable only in urban sites (84% vs. 37%, p < 0.0001); viral suppression was poor (33% vs. 53%, p = 0.08); adequate switch to second-line varied (38.1% vs. 100%, p = 0.384).

conclusionAmong adolescents on ART in Cameroon, dispensing practices are appropriate, while adherence to ART program and viral load coverage are better in urban settings. However, in both urban and rural settings, pharmacy stock outs, poor viral suppression and inadequate switch to second-line among adolescents require corrective public-health actions to limit HIVDR and to improve transition towards adult care in countries sharing similar programmatic features.

Indexed as

Drug Resistance, ViralAdolescentAnti-Retroviral AgentsCameroonChildDrug MonitoringFemaleHIV-1HIV InfectionsHumansMaleQuality Indicators, Health CareRural PopulationUrban PopulationViral LoadYoung AdultAnti-Retroviral AgentsAdolescentsAntiretroviral treatmentCameroonHIV drug resistanceProgramme quality indicators

Identifiers

PMID32398107
PMCPMC7216382
OpenAlexW3026701162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.